Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rhinaction
- Development stage
- Unknown
- Lead developer
- Laboratoire de la Mer
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Intranasal
01
Overview
Rhinaction is a natural nasal decongestant spray classified as a Class IIa Medical Device in Europe. Developed by Laboratoire de la Mer, it is indicated for the relief of symptoms associated with acute rhinitis (common cold), colds, and rhinopharyngitis in adults and children over 3 years of age. The formulation consists of hypertonic seawater (2.2% total salts) combined with a complex of three essential oils: Ravintsara, Thyme Linalool, and Field Mint. It works through an osmotic mechanism, drawing fluid from swollen nasal tissues to reduce congestion, while also fluidifying excess mucus and purifying the nasal cavities. Unlike conventional pharmacological decongestants, Rhinaction is free of vasoconstrictors (such as xylometazoline) and corticosteroids, and it does not cause rebound effects or habituation.
- Brand names
- Rhinaction
02
Targets
GABRR (GABA-A receptor subunit rho)TRPA1 (Transient receptor potential cation channel subfamily A member 1)TRPM8 (Transient receptor potential cation channel subfamily M member 8)
Beyond the preview
Go deeper on Rhinaction.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rhinaction.